Ignite Creation Date:
2025-12-25 @ 2:03 AM
Ignite Modification Date:
2026-03-06 @ 2:11 AM
Study NCT ID:
NCT02091960
Status:
COMPLETED
Last Update Posted:
2025-04-04
First Post:
2014-03-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Assess the Efficacy and Safety of Enzalutamide With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2 Positive (HER2+), Androgen Receptor Positive (AR+) Metastatic or Locally Advanced Breast Cancer
Sponsor:
Astellas Pharma Global Development, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-09-05
Start Date Type:
ACTUAL
Primary Completion Date:
2017-02-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-01-30
Completion Date Type:
ACTUAL
First Submit Date:
2014-03-18
First Submit QC Date:
None
Study First Post Date:
2014-03-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-02-27
Results First Submit QC Date:
None
Results First Post Date:
2018-05-16
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-03
Last Update Post Date:
2025-04-04
Last Update Post Date Type:
ACTUAL